Healthcare: Agency health chief leaves for Celgene

Aoife Kilkenny, head of healthcare public affairs at Fleishman-Hillard, is quitting the agency to head up comms at multinational biopharmaceutical company Celgene.

Kilkenny is leaving next month after three years at F-H. Her new role will include overseeing the UK corporate communications for the firm's drugs portfolio. She will also concentrate on market access activities.

Celgene appeared in a documentary earlier this year examining the National Institute for Health and Clinical Excellence's drug approval process. Adam Wishart's documentary The Price of Life followed the process for a new cancer drug, Revlimid, which is made by Celgene.

F-H is currently recruiting for her replacement. Kilkenny joined F-H in 2006 as deputy head of healthcare public affairs from Media Strategy (PRWeek, 9 March 2006). She became head of the public affairs practice in March last year.

Kilkenny also previously worked as director of comms and public affairs at the Association of British Healthcare Industries and as a senior consultant at Hanover.

Earlier this month PRWeek revealed F-H was overhauling its medical education function following the departure of longstanding staffer Kate Hawker (PRWeek, 9 September).

F-H is merging its medical education practice The Remedy into its healthcare PR division, following the departure of two senior directors. The Remedy founder Hawker has left to set up a new medical comms shop with Charlotte Florence, a fellow director at the med ed practice.

Separately, F-H has been hired by International SOS, the medical assistance provider, which also specialises in international healthcare and security services.

The company has selected F-H to raise the profile of the organisation among its key stakeholders in the UK.

F-H London will build brand recognition of International SOS, positioning the organisation as a provider of expert services and consultancy in the travel risk management arena.

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Latest Articles

Max Clifford trial jury finishes sixth day of deliberations

Max Clifford trial jury finishes sixth day of deliberations

The jury in the trial of celebrity publicist Max Clifford on 11 charges of indecent assault has been sent home and will reconvene tomorrow morning for a seventh day of deliberations.

Analysis: Fishburn chiefs keep eyes on future despite mounting departures

Analysis: Fishburn chiefs keep eyes on future despite mounting departures

Fishburn's management have defended their reinvention of the 23-year-old agency amid industry mutterings, fed by a series of director-level departures, about the direction in which it is going.

Hit or Miss? EasyJet backs Shakespeare Day campaign with world record attempt

Hit or Miss? EasyJet backs Shakespeare Day campaign with world record attempt

EasyJet aimed to break the world record for the highest ever theatrical performance for Shakespeare's 450th birthday yesterday with the Reduced Shakespeare Company performing on a flight from Gatwick to Verona.

Top PRs to gather in Barcelona for inaugural PRWeek Global Congress

Top PRs to gather in Barcelona for inaugural PRWeek Global Congress

Senior executives from IBM, Nestlé, Vedanta, GE, Cargill, Philips and Allianz will be among the speakers at PRWeek's first Global Congress.